UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                   FORM 10-QSB

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                   OF THE SECURITIES AND EXCHANGE ACT OF 1934
        ---------------------------------------------------------------
       For the Quarter Ended January 31, 2004, Commission File Number 0-32887



                                  MYOCASH, INC.
              -----------------------------------------------------
             (Exact name of Registrant as specified in its charter)


                           Nevada              n/a
        ---------------------------  ----------------------------------
       (State of Incorporation) (I.R.S. Employer Indentification Number)


                  14 Pico Crescent, Thornhill, Ontario L4J 8P4
              ------------------------------------------------------
               (address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (905) 731-0189


                                 Not Applicable
       -------------------------------------------------------------------
       (Former name, address, or fiscal year if changed since last report)

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  and Exchange Act
of 1934  during the  preceding  12 months (or for such  shorter  period that the
Registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

                           Yes         x                No
                                  ------------        ------------
     The total number of shares  outstanding of the issuer's common shares,  par
value $ .001 as of the date of this report, follow:

                             6,250,000


<PAGE>






PART I - FINANCIAL INFORMATION

Item 1.           Financial Statements


                                 MYOCASH, INC.


                          INTERIM FINANCIAL STATEMENTS


                                JANUARY 31, 2004
                                  (UNAUDITED)





<PAGE>


                                 MYOCASH, INC.
                             INTERIM BALANCE SHEET
                             AS AT January 31, 2004
                                 (UNAUDITED)

<TABLE>
<CAPTION>

                                                     January 31,  October 31,
                                                        2004         2003
                                                     (UNAUDITED)  (AUDITED)

ASSETS

Current Assets
<S>                                                 <C>               <C>
Cash ...............................................$    --           $    --

                                                     --------          ---------

Total Current Assets ..............................      --                --
                                                     --------          ---------

OTHER -  AT COST
Goodwill ..............................................  --                --
Incorporation costs ...................................  --                --
                                                     --------          ---------

Total Other Assets                                       --                --
                                                     --------          ---------


TOTAL ASSETS                                        $    --            $   --
                                                     ========          =========

</Table>

The accompanying notes are an integral part of these financial statements.

<Page>

                                 MYOCASH, INC.
                             INTERIM BALANCE SHEET
                             AS AT January 31, 2004
                                  (UNAUDITED)
<TABLE>
<CAPTION>

                                                   January 31,  October 31,
                                                      2004         2003

LIABILITIES
<S>                                                <C>               <C>
Accounts payable ...................................$   1,500        $   1,500

LONG-TERM
Due to shareholders                                      --               --
                                                     --------          ---------


Total Liabilities ..................................    1,500            1,500
                                                     --------          ---------

STOCKHOLDERS' EQUITY

Preferred stock, authorized 5,000,000 shares par value
$ .001, none outstanding
Common stock, authorized 50,000,000 shares, par value
$ .001 - 6,250,000 issued and outstanding,
    (October 31, 2003 - 6,250,000)                      6,250            6,250

Additional paid-in capital ..                            --                --
Deficit, accumulated during the development stage      (7,750)          (7,750)
                                                      -------          ---------
                                                       (1,500)          (1,500)
                                                      -------          ---------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY           $   --          $     --
                                                      ========         =========

</Table>


The accompanying notes are an integral part of these financial statements.
<Page>



                                 MYOCASH, INC.
                        INTERIM STATEMENT OF OPERATIONS
                  For the Three Months Ended January 31, 2004
                                (UNAUDITED)

<TABLE>
<CAPTION>

                                                                   FROM
                                                                INCEPTION
                                                              (Nov 17, 2000)
                                          THREE MONTHS ENDED       TO
                                             JANUARY 31,        JANUARY 31,
                                          2004     2003            2004
<S>                                      <C>        <C>       <C>
REVENUE .................................$.  --...  $    --    $    --
                                          --------   --------   --------


OPERATING EXPENSES
Professional fees                            --          --       1,500
Amortization expenses                        --          --         --
General and administrative                   --          --       6,250
                                          --------   --------   --------

Total Operating Expenses                     --          --       7,750
                                          --------   --------   --------

NET LOSS FROM OPERATIONS                 $   --     $    --   $  (7,750)
                                          ========   ========   ========

Weighted Average Number of
  Common Shares Outstanding              6,250,000  6,250,000
                                         =========  =========
Net Loss Per Share                         $ --       $  --
                                           =======     ======
</TABLE>

The accompanying notes are an integral part of these financial statements.
<PAGE>


                                 MYOCASH, INC.
                        INTERIM STATEMENT OF CASH FLOWS
                     For the Three Months Ended January 31, 2004
                                  (UNAUDITED)
<TABLE>
<CAPTION>


                                                                   FROM
                                                                 INCEPTION
                                                              (Nov 17, 2000)
                                           THREE MONTHS ENDED       TO
                                              JANUARY 31,       JANUARY 31,
                                             2004     2003         2004

<S>                                         <C>     <C>           <C>

Cash Flows From Operating Activities
Net income(loss) for the period ..........$...--...  $    --      $  (7,750)
                                           --------   --------     --------

Adjustments to reconcile net loss to net
 cash in operating activities:
      Stock issued for services         ..... --          --          5,705
      Stock issued for reimbursement
       of incorporation costs                 --          --            545
   Changes in assets and liabilities
      Accounts receivable ....................--......    --           --
      Accounts payable ...................... --......    --          1,500
                                           --------   --------      -------
                                              --          --          7,750
                                           --------   --------      -------

Net Cash Provided By(Used in)
     Operating Activities                     --          --           --
                                           --------   --------      -------

Cash Flows From Investing Activities
Purchase of goodwill ........................ --          --           --
Incorporation costs ........................  --          --           --
                                           --------   --------      -------

Net Cash Used in Investing Activities ........--          --           --
                                           --------   --------      -------

Cash Flow From Financing Activities
Advances from shareholders ...................--          --           --
Issuance of common stock .....................--......    --           --
                                           --------   --------      -------
                                              --          --           --
                                           --------   --------      -------


Increase(decrease) in Cash ..............     --          --           --

Cash and Cash Equivalents - Beginning of
       period                                 --          --           --
                                           --------   --------      -------

Cash and Cash Equivalents - End of
       period ........                    $   --     $    --      $    --
                                           ========   ========      =======

Supplementary Information
  Interest paid ..........................$   --     $    --      $    --
                                           ========   ========      =======
  Taxes paid .............................$   --     $    --      $    --
                                           ========   ========      =======
</TABLE>


The accompanying notes are an integral part of these financial statements.
<PAGE>



                                 MYOCASH, INC.
              INTERIM STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
             From Inception(November 17, 2000) to January 31, 2004
                                  (UNAUDITED)
<TABLE>
<CAPTION>


                                                        Deficit
                                                     Accumulated
                                        Additional    During the
                       Common Stock      Paid-In     Development
                     Shares   Amount     Capital       Stage        Totals
              ---------------------------------------------------------------
<S>                <C>         <C>      <C>        <C>            <C>

Balance - November
  17, 2000             --      $   --    $    --    $     --       $    --

Stock issued for
  services          4,455,000    4,455        --          --           4,455

Stock issued for
 incorporation costs  545,000      545        --          --             545


Net loss for period                                     (5,000)       (5,000)
                    ---------  -------    ---------   --------      --------

BALANCE - October 31,
     2001           5,000,000    5,000        --        (5,000)         --

Stock issued for
  services          1,250,000    1,250        --          --           1,250

Net loss for
    year               --         --          --        (1,250)       (1,250)
                   ----------  -------    ---------   --------      --------
Balance - October
   31, 2002         6,250,000    6,250        --        (6,250)         --

Stock issued for
  services             --         --          --          --            --

Net loss for
    year               --         --          --        (1,500)       (1,500)
                   ----------  -------    ---------   --------      --------
Balance - October
   31, 2003         6,250,000    6,250        --        (7,750)       (1,500)

Net loss - January
   31, 2004            --         --          --          --            --
                   ----------  -------    ---------   --------      --------
Balance - January
   31, 2004         6,250,000 $  6,250   $    --     $  (7,750)    $  (1,500)
                   ==========  =======    ========    ========      ========
</TABLE>


The accompanying notes are an integral part of these financial statements.













<PAGE>


                                  MYOCASH, INC.
                          (A Development Stage Company)
                      Notes To Interim Financial Statements
                                January 31, 2004
                                   (UNAUDITED)

Note 1 - Organization and Summary of Significant Accounting Policies:

     Nature of Business

     MYOCASH,  INC., (the "Company") was incorporated on November 17, 2000 under
the laws of the State of Nevada.  The Company's primary business  operations are
to and engage in the acquisition of a technology  based company.  The Company is
searching  for a viable entity upon which to merge and/or  acquire.  The Company
intends on going public in order to raise the funds required in order to fulfill
its business objectives.

     The Company's fiscal year end is October 31,

     Basis of  Presentation

     Development  Stage  Company

     The Company has not earned any revenue from limited  principal  operations.
Accordingly,  the  Company's  activities  have been  accounted for as those of a
Development  Stage  Enterprise' as set forth in Financial  Accounting  Standards
Board Statement No. 7 ("SFAS 7"). Among the  disclosures  required by SFAS 7 are
that the Company's financial  statements be identified as those of a development
stage  company,  and that the  statements of  operations,  stockholders"  equity
(deficit)  and cash  flows  disclose  activity  since the date of the  Company's
inception.

     Basis of Accounting

     The  accompanying  financial  statements  have been prepared on the accrual
basis of accounting in accordance with generally accepted accounting principles.
In the opinion of management,  these interim  financial  statements  include all
adjustments necessary in order to make them not misleading.

     Estimates

     The  preparation  of financial  statements  in  conformity  with  generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions that affect certain  reported amounts and disclosures.  Accordingly,
actual results could differ from those estimates.

     Cash and Cash Equivalents

     For purposes of the  statement of cash flows,  the Company  considered  all
cash and other highly liquid investments with initial maturities of three months
or less to be cash equivalents.

<PAGE>

                                  MYOCASH, INC.
                          (A Development Stage Company)
                      Notes To Interim Financial Statements
                                January 31, 2004
                                   (UNAUDITED)


     Net earning (loss) per share

     Basic and diluted net loss per share  information  is  presented  under the
requirements  of SFAS No. 128,  Earnings per Share.  Basic net loss per share is
computed by dividing net loss by the weighted average number of shares of common
stock outstanding for the period, less shares subject to repurchase. Diluted net
loss per share  reflects the  potential  dilution of  securities by adding other
common stock equivalents, including stock options, shares subject to repurchase,
warrants and  convertible  preferred  stock, in the  weighted-average  number of
common shares  outstanding for a period, if dilutive.  All potentially  dilutive
securities  have  been  excluded  from  the  computation,  as  their  effect  is
anti-dilutive.

     Income Taxes

     The Company  accounts for income taxes under SFAS No. 109,  which  requires
the asset and  liability  approach to accounting  for income  taxes.  Under this
method,  deferred tax assets and  liabilities  are measured based on differences
between  financial  reporting and tax bases of assets and  liabilities  measured
using  enacted  tax  rates  and laws  that are  expected  to be in  effect  when
differences are expected to reverse.

Note 2 - Capital Stock Transactions

     The authorized capital common stock is 50,000,000 shares of common stock at
$.001 par value.  The  Company  has issued  6,250,000  of common  stock of which
5,705,000 was for services rendered as  administrative  expenses by the founders
at a cost of $5,705 and $ 545 for incorporation costs which were expensed in the
prior fiscal years ended October 31, 2002 and October 31, 2001.
..

<PAGE>



                                  MYOCASH, INC.
                          (A Development Stage Company)
                      Notes To Interim Financial Statements
                                January 31, 2004
                                   (UNAUDITED)


Note 3 - Going Concern:

     The accompanying financial statements have been prepared in conformity with
generally accepted accounting principles, which contemplates continuation of the
Company as a going concern.  The Company operations are in the development stage
and the Company has  generated no income.  The future  success of the Company is
likely  dependent  on its  ability to attain  additional  capital to develop its
proposed  products and ultimately,  upon its ability to attain future profitable
operations.  There can be no assurance  that the Company will be  successful  in
obtaining  such  financing,  or that it will  attain  positive  cash  flow  from
operations.

Note 4 -Income Taxes

     There has been no provision  for U.S.  federal,  state,  or foreign  income
taxes for any period because the Company has incurred  losses in all periods and
for all jurisdictions.

     Deferred income taxes reflect the net tax effects of temporary  differences
between the carrying  amounts of assets and liabilities for financial  reporting
purposes and the amounts used for income tax purposes. Significant components of
deferred tax assets are as follows:

Deferred tax assets
  Net operating loss carryforwards                       $  7,750
  Valuation allowance for deferred tax assets              (7,750)
                                                          -------
Net deferred tax assets                                  $    -
                                                          =======

     Realization  of deferred tax assets is dependent upon future  earnings,  if
any, the timing and amount of which are uncertain. Accordingly, the net deferred
tax assets have been fully  offset by a valuation  allowance.  As of January 31,
2004, the Company had net operating loss  carryforwards of approximately $ 7,750
for federal and state income tax purposes. These carryforwards,  if not utilized
to  offset  taxable  income  begin to  expire  in 2017.  Utilization  of the net
operating  loss may be  subject  to  substantial  annual  limitation  due to the
ownership change  limitations  provided by the Internal Revenue Code and similar
state  provisions.  The annual  limitation could result in the expiration of the
net operating loss before utilization.







<PAGE>


Item 2:           Management's Discussion and Analysis or Plan Of Operation

     THE  FOLLOWING  DISCUSSION OF THE RESULTS OF OUR  OPERATIONS  AND FINANCIAL
CONDITION  SHOULD BE READ IN CONJUNCTION  WITH OUR FINANCIAL  STATEMENTS AND THE
NOTES  THERETO  INCLUDED  ELSEWHERE  IN THIS REPORT.  EXCEPT FOR THE  HISTORICAL
INFORMATION  CONTAINED HEREIN, THE DISCUSSION  CONTAINED IN THIS REPORT CONTAINS
"FORWARD-LOOKING   STATEMENTS"  THAT  INVOLVE  RISK  AND  UNCERTAINTIES.   THESE
STATEMENTS MAY BE IDENTIFIED BY THE USE OF  FORWARD-LOOKING  TERMINOLOGY SUCH AS
"BELIEVES,"  "EXPECTS," "MAY," "WILL," "SHOULD" OR "ANTICIPATES" OR THE NEGATIVE
THEREOF OR SIMILAR  EXPRESSIONS OR BY  DISCUSSIONS  OF STRATEGY.  THE CAUTIONARY
STATEMENTS MADE IN THIS REPORT SHOULD BE READ AS BEING APPLICABLE TO ALL RELATED
FORWARD-LOOKING  STATEMENTS  WHEREVER  THEY  APPEAR IN THIS  REPORT.  OUR ACTUAL
RESULTS COULD DIFFER MATERIALLY FROM THOSE DISCUSSED IN THIS REPORT.

Results of Operations

     For the three months ended January 31, 2004,  the Company has not generated
any  revenues.  Management's  efforts to date have been  devoted to  focusing on
raising capital in order to fulfil its business objectives.  To date, management
has been  unsuccessful.  The Company has  incurred  operating  losses to date of
$7,750 and will  continue  to incur  losses  until  such time as an  acquisition
candidate  is  identified  and,  even if  successful  in acquiring a business or
consummating  a  business  combination,  there  can be no  assurance  that  this
business will be profitable.


Liquidity and Capital Resources

     The  Company  has no  cash.  The  investigation  of  prospective  financing
candidates involves the expenditure of capital.  The Company will likely have to
look to Mr. Marvin Winick or to third parties for additional capital.  There can
be no assurance that the Company will be able to secure additional  financing or
that the amount of any  additional  financing will be sufficient to conclude its
business objectives or to pay ongoing operating expenses.

ITEM 3.  CONTROLS AND PROCEDURES

     (a) Within the 90-day time period prior to filing this report, we conducted
as  an  evaluation  of  the  effectiveness  of  our  "disclosure   controls  and
procedures,"  as that phrase is defined in Rules  13a-14(c) and 15d-14(c)  under
the  Securities  Exchange Act of 1934.  The evaluation was carried out under the
supervision and with the participation of management, including our President.

     Based  on and  as of the  date  of  that  evaluation,  our  President  have
concluded  that our  disclosure  controls and procedures are effective in timely
alerting him to material  information required to be disclosed in the reports we
file with or submit to the Securities and Exchange  Commission ("SEC") under the
Securities  Exchange Act of 1934, and in ensuring that the information  required
to be disclosed in those filings is recorded, processed, summarized and reported
within the time periods specified in the SEC's rules and forms.

     Nothwithstanding  the  foregoing,  there  can  be  no  assurance  that  the
Company's disclosure controls and procedures will detect or uncover all failures
of  persons  within the  Company  to  disclose  material  information  otherwise
required to be set forth in the Company's  periodic reports.  There are inherent
limitations  to the  effectiveness  of any  system of  disclosure  controls  and
procedures,  including the possibility of human error and the  circumvention  or
overriding  of  the  controls  and  procedures.   Accordingly,   even  effective
disclosure  controls and procedures can only provide  reasonable,  not absolute,
assurance of achieving their control objectives.

     (b)  Subsequent to the date of the  evaluation,  there were no  significant
changes in internal controls or in other factors that could significantly affect
the internal  controls,  including any  corrective  actions taken with regard to
significant deficiencies and material weaknesses.


                          PART II - OTHER INFORMATION

Item 1:           Legal Proceedings

There are no legal proceedings applicable.

Item 2:           Changes in Securities and Use of Proceeds

Not Applicable

Item 3:           Defaults upon Senior Securities

Not Applicable.

Item 4:           Submission of Matters to a Vote of Security Holders

Not Applicable

Item 5:           OTHER INFORMATION

     None

Item 6:           Exhibits and Reports on Form 8-K

     Exhibit 11 -  Computation  of earnings per common share - see  Statement
                    Of Operations

     Reports on Form 8-K - None


    Exhibit 31 & 32   Certifications
<PAGE>



                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant has duly caused this report to be signed by the undersigned thereunto
duly authorized.

          MYOCASH, INC.

BY:      /s/   Marvin Winick
         -------------------------------
         Marvin Winick, President

Dated:   December 7, 2004

<PAGE>

Exhibit 31.1

                           CERTIFICATION PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
                            (18 U.S.C. SECTION 1350)




I, Marvin N. Winick, certify that;


     1. I have reviewed this quarterly report on Form 10-QSB of Myocash, Inc.

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
registration as of, and for, the periods presented in this quarterly report;

     4. I am responsible for  establishing and maintaining  disclosure  controls
and  procedures  (as  defined in Exchange  Act Rules  13a-14 and 15d-14) for the
registrant and have:

     a) designed such disclosure  controls and procedure to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others  within those  entities,  particularly  during the
period in which this quarterly report is being prepared;

     b) evaluated the effectiveness of the registrant's  disclosure controls and
procedures  as of a date  within  90  days  prior  to the  filing  date  of this
quarterly report (the "Evaluation Date"); and

     c)  presented  in  this  quarterly   report  our   conclusions   about  the
effectiveness of the disclosure  controls and procedures based on our evaluation
as of the Evaluation Date;

     5.  I  have  disclosed,  based  on  our  most  recent  evaluation,  to  the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

     a) all  significant  deficiencies  in the design or  operation  of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and have  identified  for the
registrant's auditors any material weaknesses in internal controls; and

     b) any fraud,  whether or not material,  that involves  management or other
employees who have a significant role in the registrant's internal controls; and

<PAGE>

     6. I have indicated in this quarterly report whether there were significant
changes in internal controls or in other factors that could significantly affect
internal  controls  subsequent  to the  date  of  our  most  recent  evaluation,
including any  corrective  actions with regard to significant  deficiencies  and
material weaknesses.





                                       /s/ Marvin Winick
                           ---------------------------------------------
                                        Marvin Winick
                                         President





December 7, 2004

<PAGE>






                                                                    EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
                            (18 U.S.C. SECTION 1350)



     In  connection  with  the  Quarterly  Report  of  Myocash,  Inc.,  a Nevada
corporation (the  "Company"),  on Form 10-QSB for the quarter ending January 31,
2004 as filed with the Securities and Exchange  Commission  (the  "Report"),  I,
Marvin N. Winick President & CEO, of the Company,  certify,  pursuant to Section
906 of the  Sarbanes-Oxley  Act of 2002 (18  U.S.C.  Section  1350),  that to my
knowledge:

     1. The Report fully  complies  with the  requirements  of section  13(a) or
15(d) of the Securities Exchange Act of 1934; and

     2. The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.



                                            /s/ Marvin Winick
                             -------------------------------------------
                                             Marvin N. Winick
                                             President & CEO


December 7, 2004.